Stay updated on Autologous TILs in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Metastatic TNBC Clinical Trial page.
Latest updates to the Autologous TILs in Metastatic TNBC Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check13 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check49 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check64 days agoChange DetectedNew efficacy evaluation metrics for autologous LN-145 in Metastatic Triple Negative Breast Cancer patients have been added, focusing on duration of response, disease control rate, median progression-free survival, and overall survival, while several previous metrics have been removed.SummaryDifference6%
- Check71 days agoChange DetectedSeveral key health-related URLs have been removed, including those related to genetics and breast cancer information, which may impact access to important medical resources.SummaryDifference0.4%
Stay in the know with updates to Autologous TILs in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Metastatic TNBC Clinical Trial page.